P809: BASELINE CHARACTERISTICS IDENTIFYING PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IDECABTAGENE VICELEUCEL (IDE-CEL; BB2121) WHO ARE AT RISK FOR SEVERE/REFRACTORY INFLAMMATORY... par Afshin Mashadi-Hossein, Julie Rytlewski, MD Shamsuzzaman, Debashree Basudhar, Mandeep Takhar, Ana Kostic, Timothy B. Campbell, Salomon Manier, Yi Lin, Nathan Martin

Accéder au texte intégral

Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype par Mayumi Fujita, Veena Somasundaram, Debashree Basudhar, Robert Y.S. Cheng, Lisa A. Ridnour, Harumi Higuchi, Kaori Imadome, Jae Hong No, Gaurav Bharadwaj, David A. Wink

Accéder au texte intégral

Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level par Veena Somasundaram, Anne C. Gilmore, Debashree Basudhar, Erika Mariana Palmieri, David A. Scheiblin, William F. Heinz, Robert.Y.S. Cheng, Lisa A. Ridnour, Grégoire Altan-Bonnet, Stephen J. Lockett, Daniel W. McVicar, David A. Wink

Accéder au texte intégral

P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C par Melissa Alsina, Madhav Dhodapkar, Jesus Berdeja, Krina Patel, Shambavi Richard, Ravi Vij, Xavier Leleu, Daniel Egan, P. Leif Bergsagel, Reshef Ran, Saad Z Usmani, Anna Truppel-Hartmann, Debashree Basudhar, Ethan Thompson, Xirong Zheng, Xiaobo Zhong, Chiara Greggio, Mihaela Popa Mckiver, Marlene Carrasco Alfonso, David Siegel

Accéder au texte intégral